Term: idarucizumab
IPA: ˌaɪ.də.ɹuˈsɪz.əˌmæb

==English==
{{wp}}

===Etymology===
From {{af|en|idaru-|-ci-|-zumab|qq1=of unknown origin|t2=cardiovascular|t3=humanized monoclonal antibody}}.

===Pronunciation===
* {{IPA|en|/ˌaɪ.də.ɹuˈsɪz.əˌmæb/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} A [[monoclonal antibody]] designed for the reversal of [[anticoagulant]] effects of [[dabigatran]].